Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-012105

ALDER BIOPHARMACEUTICALS INC · ALDR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 11, 2015
Accepted (ET)
Aug 13, 2015 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 11, 2015S115,358$40.4026D1,909,125ISee Footnote
Common StockF3,F4Aug 12, 2015S97,109$40.0314D1,812,016ISee Footnote
Common StockF6Aug 12, 2015J1,795,752$0.00D16,264ISee Footnote
Common StockF7,F8Aug 12, 2015J42$0.00A16,306ISee Footnote
Common StockF9Aug 12, 2015J4,115$0.00A8,662D
Common StockF10Aug 12, 2015J1,259$0.00A2,651D
Common StockF11Aug 12, 2015J3,316$0.00A6,980D
Common StockF12Aug 12, 2015J3,316$0.00A6,980D
Common StockF13Aug 15, 2015J2,517$0.00A5,299D
Common StockF14Aug 12, 2015J2,118$0.00A4,458D
Common StockF15Aug 12, 2015J4,115$0.00A8,662D
Common StockF16Aug 12, 2015J2,118$0.00A4,458D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses